微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.55% | 7.06% | -67.17% | 16/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 13.86% | 2.82% | 19.17% | 15/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 11.63% | 2.2% | 46.66% | 19/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 7.93% | 4.2% | 86.59% | 18/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 4.25% | 3.16% | -68.47% | 11/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 13.48% | -4.33% | 18.45% | 16/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 11.38% | 0.35% | 49.54% | 15/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 7.61% | -2.93% | 84.71% | 15/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 4.12% | -1.2% | -70.76% | 16/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 14.09% | 7.39% | 24.25% | 21/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 11.34% | -3.65% | 44.64% | 25/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 7.84% | 4.67% | 88.01% | 22/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 4.17% | -1.18% | -68.22% | 16/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 13.12% | 5.81% | 11.47% | 28/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 11.77% | -5.39% | 57.14% | 23/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 7.49% | 3.17% | 77.49% | 29/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 4.22% | 20.23% | -65.97% | 18/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 12.4% | 12.73% | -0.32% | 41/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 12.44% | 29.18% | 71.35% | 25/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 7.26% | 20% | 106.84% | 33/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 3.51% | -3.04% | -68.09% | 24/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11% | 23.73% | 14.23% | 53/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 9.63% | 10.82% | 59.17% | 37/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.05% | 15.9% | 67.13% | 39/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.62% | 13.84% | -59.28% | 25/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 8.89% | -6.22% | 2.3% | 57/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.69% | -82.42% | 66.48% | 35/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.22% | -22.09% | 64.15% | 36/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.18% | -23.19% | -66.46% | 27/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 9.48% | -29.62% | -80.82% | 52/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 49.43% | 273.06% | 637.76% | 1/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 6.7% | -15.83% | 61.84% | 30/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 4.14% | -19.77% | -69.27% | 11/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 13.47% | 0.45% | 1.66% | 39/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 13.25% | 5.41% | 66.46% | 15/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 7.96% | 10.25% | 54.26% | 23/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 5.16% | 7.28% | -61.52% | 12/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 13.41% | 1.98% | 6.68% | 39/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 12.57% | 3.97% | 74.1% | 16/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 7.22% | -7.08% | 50.1% | 22/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 4.81% | 14.52% | -63.42% | 13/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |